skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Reduction in Cerebrospinal Fluid Volume as an Early Quantitative Biomarker of Cerebral Edema After Ischemic Stroke

Stroke (1970), 2020-02, Vol.51 (2), p.462-467 [Peer Reviewed Journal]

2020 American Heart Association, Inc. ;ISSN: 0039-2499 ;EISSN: 1524-4628 ;DOI: 10.1161/STROKEAHA.119.027895 ;PMID: 31818229

Full text available

Citations Cited by
  • Title:
    Reduction in Cerebrospinal Fluid Volume as an Early Quantitative Biomarker of Cerebral Edema After Ischemic Stroke
  • Author: Dhar, Rajat ; Chen, Yasheng ; Hamzehloo, Ali ; Kumar, Atul ; Heitsch, Laura ; He, June ; Chen, Ling ; Slowik, Agnieszka ; Strbian, Daniel ; Lee, Jin-Moo
  • Subjects: Aged ; Aged, 80 and over ; Biomarkers ; Brain Edema - diagnostic imaging ; Brain Edema - etiology ; Brain Ischemia - complications ; Brain Ischemia - diagnostic imaging ; Cerebrospinal Fluid - diagnostic imaging ; Cohort Studies ; Female ; Humans ; Male ; Middle Aged ; Odds Ratio ; Organ Size ; Severity of Illness Index ; Stroke - complications ; Stroke - diagnostic imaging ; Tomography, X-Ray Computed
  • Is Part Of: Stroke (1970), 2020-02, Vol.51 (2), p.462-467
  • Description: BACKGROUND AND PURPOSE—Cerebral edema (CED) develops in the hours to days after stroke; the resulting increase in brain volume may lead to midline shift (MLS) and neurological deterioration. The time course and implications of edema formation are not well characterized across the spectrum of stroke. We analyzed displacement of cerebrospinal fluid (ΔCSF) as a dynamic quantitative imaging biomarker of edema formation. METHODS—We selected subjects enrolled in a stroke cohort study who presented within 6 hours of onset and had baseline and ≥1 follow-up brain computed tomography scans available. We applied a neural network-based algorithm to quantify hemispheric CSF volume at each imaging time point and modeled CSF trajectory over time (using a piecewise linear mixed-effects model). We evaluated ΔCSF within the first 24 hours as an early biomarker of CED (defined as developing MLS on computed tomography beyond 24 hours) and poor outcome (modified Rankin Scale score, 3–6). RESULTS—We had serial imaging in 738 subjects with stroke, of whom 91 (13%) developed CED with MLS. Age did not differ (69 versus 70 years), but baseline National Institutes of Health Stroke Scale was higher (16 versus 7) and baseline CSF volume lower (132 versus 161 mL, both P<0.001) in those with CED. ΔCSF was faster in those developing MLS, with the majority seen by 24 hours (36% versus 11% or 2.4 versus 0.8 mL/h; P<0.0001). Risk of CED almost doubled for every 10% ΔCSF within 24 hours (odds ratio, 1.76 [95% CI, 1.46–2.14]), adjusting for age, glucose, and National Institutes of Health Stroke Scale. Risk of neurological deterioration (1.6-point increase in National Institutes of Health Stroke Scale at 24 hours) and poor outcome (adjusted odds ratio, 1.34 [95% CI, 1.15–1.56]) was also greater for every 10% increase in ΔCSF. CONCLUSIONS—CSF volumetrics provides quantitative evaluation of early edema formation. ΔCSF from baseline to 24-hour computed tomography is a promising early biomarker for the development of MLS and worse neurological outcome.
  • Publisher: United States: American Heart Association, Inc
  • Language: English
  • Identifier: ISSN: 0039-2499
    EISSN: 1524-4628
    DOI: 10.1161/STROKEAHA.119.027895
    PMID: 31818229
  • Source: MEDLINE
    Alma/SFX Local Collection

Searching Remote Databases, Please Wait